Stemnovate

Stemnovate is a UK-based private biotechnology company developing an integrated drug discovery and disease-modelling platform built around stem cells, multi-omics, microengineering, computational modelling, and data analytics. The company focuses on multi-organ in vitro models for liver, heart, and brain applications to improve drug metabolism, toxicity testing, and translational research while reducing reliance on animal testing. In addition to platform services, Stemnovate offers biobanking, cellular reprogramming, differentiation, assay automation, and custom research services for pharmaceutical and academic customers. The company has highlighted work in rare pediatric mitochondrial disease, Parkinson's disease, hepatitis, and neurodegeneration research, and also markets diagnostic and cell-based products. Stemnovate appears to be primarily a platform and services business rather than a clinical-stage therapeutic developer.